Valuation: Alkem Laboratories Limited

Market Cap 62TCr 651.06Cr 581.26Cr 533.39Cr 485.21Cr 909.69Cr 927.82Cr 6.37TCr 2.57TCr 33TCr 2.44TCr 2.39TCr 1,02800Cr P/E 2027 *
26.9x
P/E 2028 * 23.3x
Enterprise Value 60TCr 637.19Cr 568.89Cr 522.04Cr 474.87Cr 890.32Cr 908.06Cr 6.24TCr 2.51TCr 32TCr 2.39TCr 2.34TCr 1,00600Cr EV / Sales 2027 *
3.61x
EV / Sales 2028 * 3.16x
Free-Float
38.63%
Yield 2027 *
0.98%
Yield 2028 * 1.07%
1 day+0.81%
1 week+4.20%
Current month+0.81%
1 month-1.25%
3 months-10.37%
6 months-4.54%
Current year-6.38%
1 week 4,963
Extreme 4963
5,166
1 month 4,811
Extreme 4811
5,407
Current year 4,811
Extreme 4811
5,933.5
1 year 4,811
Extreme 4811
5,933.5
3 years 3,783.55
Extreme 3783.55
6,439.9
5 years 2,828
Extreme 2828
6,439.9
10 years 1,455
Extreme 1455
6,439.9
Manager TitleAgeSince
President - -
President - -
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 44 09/08/2013
Director/Board Member 63 11/02/2008
Director/Board Member 45 11/11/2019
Change 5-day change 1-year change 3-year change Capi.($)
+0.81%+4.20%-6.38%+38.48% 643.91Cr
-0.58%+10.37%+57.47%+143.28% 1,26300Cr
-1.49%+1.09%+44.53%+79.18% 66TCr
-2.33%+0.55%+36.03%+101.26% 52TCr
-1.54%+0.18%+53.06%+66.79% 39TCr
-0.36%+5.63%+80.06%+44.41% 37TCr
-1.69%+3.17%+32.18%+55.35% 31TCr
-0.72%+7.83%+12.10%+33.76% 29TCr
-0.04%+4.77%+57.22%+74.74% 25TCr
-0.45%+7.32%+39.54%+109.66% 21TCr
Average -0.86%+5.65%+40.58%+74.69% 42.68TCr
Weighted average by Cap. -1.07%+6.59%+48.51%+93.09%

Financials

2027 *2028 *
Net sales 17TCr 176.35Cr 157.44Cr 144.48Cr 131.42Cr 246.4Cr 251.31Cr 1.73TCr 695.6Cr 8.81TCr 661.85Cr 647.74Cr 28TCr 19TCr 196.48Cr 175.42Cr 160.97Cr 146.43Cr 274.53Cr 280Cr 1.92TCr 775.01Cr 9.82TCr 737.41Cr 721.69Cr 31TCr
Net income 2.31TCr 24Cr 22Cr 20Cr 18Cr 34Cr 35Cr 239.26Cr 96Cr 1.22TCr 92Cr 90Cr 3.86TCr 2.73TCr 29Cr 26Cr 24Cr 21Cr 40Cr 41Cr 281.93Cr 113.65Cr 1.44TCr 108.13Cr 105.83Cr 4.55TCr
Net Debt -1.31TCr -14Cr -12Cr -11Cr -10Cr -19Cr -20Cr -135.66Cr -55Cr -692.74Cr -52Cr -51Cr -2.19TCr -2.82TCr -30Cr -27Cr -24Cr -22Cr -42Cr -42Cr -291.33Cr -117.43Cr -1.49TCr -111.74Cr -109.35Cr -4.7TCr
Projected Income Statement - Annual - Alkem Laboratories Limited
Logo Alkem Laboratories Limited
Alkem Laboratories Ltd. is an India-based pharmaceutical company engaged in the development, manufacturing, and sale of pharmaceutical products. The Company operates in a single business segment-Pharmaceuticals. It produces branded generics, generic drugs, active pharmaceutical ingredients (APIs), and nutraceuticals, which it markets in India and international markets. It has a portfolio of approximately 800 brands in India and maintains a presence in over 40 international markets, with the United States being its key focus market. Its offerings include therapies, prescription (Rx) products, and Alkem generics. Its therapy offerings cover multiple medical fields, including anti-infectives, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory care, rheumatology, and urology. The Company’s subsidiaries include Ascend Laboratories (Pty) Ltd, Pharmacor Pty Limited, Alkem Laboratories Corporation, and others.
Employees
19,346
Date Price Change Volume
02/26/02 ₹5,155.00 +0.81% 1,00,190
30/26/30 ₹5,113.50 +0.68% 1,08,036
29/26/29 ₹5,079.00 +0.18% 58,530
28/26/28 ₹5,070.00 -0.16% 78,885
27/26/27 ₹5,078.00 +0.95% 1,66,281
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - Alkem Laboratories Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
5,155.00INR
Average target price
6,002.55INR
Spread / Average Target
+16.44%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Alkem Laboratories Limited
  1. Stock Market
  2. Stocks
  3. ALKEM Stock